According to the latest report by IMARC Group, titled “Nanopore Technologies Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027,” The global nanopore technologies market reached a value of US$ 213.8 Million in 2021. Looking forward, IMARC Group expects the market to reach US$ 476.6 Million by 2027, exhibiting at a CAGR of 13.7% during 2022-2027.
Nanopore technologies enable direct, real-time analysis of long deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) fragments. They help resolve complex structural variants and repetitive regions. They also offer low-cost genotyping, high mobility for testing and throughput, and fast processing of samples in real-time. Consequently, nanopore technologies are widely used as a diagnostic tool to provide rapid analysis, detect target molecules, and eliminate cumbersome amplification and conversion steps.
Request for a free sample copy of this report: https://www.imarcgroup.com/nanopore-technologies-market/requestsample
Note: We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
The coronavirus disease (COVID-19) outbreak has increased the need for nanopore technologies across the globe to develop a potential treatment. Moreover, the improving healthcare infrastructure, along with the rising prevalence of chronic, infectious, and cardiovascular diseases, is propelling the adoption of advanced nanopore technologies embedded with high-tech electronics to perform precise molecular analyses. Apart from this, the introduction of portable nanopore devices that provide real-time analysis and detection of epigenetic modifications is anticipated to offer lucrative growth opportunities to industry players.
Breakup by Product:
Breakup by Application:
- DNA Sequencing
- RNA Sequencing
Breakup by End User:
- Hospitals and Clinics
- Research Institutes
Breakup by Region:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
Competitive Landscape with Key Player:
- Agilent Technologies Inc.
- Cyclomics BV
- Electronic Biosciences Inc.
- Inanobio Inc.
- Nabsys Inc.
- Ontera Inc.
- Oxford Nanopore Technologies Limited
- Pacific Biosciences of California Inc.
- Quantapore Inc.
- Roche Holding AG
- Tracxn Technologies Limited.
Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/nanopore-technologies-market
As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.
If you want latest primary and secondary data (2022-2027) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800